Skip to content
GLP-1 Decoder

Saxenda FDA Approval: Every Indication and Date

Saxenda fda: what happened, what it means for patients, and where to read the record.

Active ingredient
liraglutide
Manufacturer
Novo Nordisk
How it is taken
Daily injection
FDA-approved for
Weight loss

Saxenda: key facts

How long it remains in the body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours. After 13 h, half is gone, and about 3% remains after five half-lives (2.7 d).

How much weight was lost in its main trial
Saxenda (SCALE Obesity and Prediabetes)7.4%Placebo3%

Against 3% on placebo, the result during SCALE Obesity and Prediabetes, 56 weeks was 7.4% of body weight.

Sources: FDA label (DailyMed).